Biodesix, Inc. (BDSX) Financials

BDSX Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 95.3 million 86.2 million
March 31, 2026 94.6 million 85.5 million
Dec. 31, 2025 87.5 million 89.9 million
Sept. 30, 2025 88.7 million 90.4 million

BDSX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -1.7 million 820000
March 31, 2026 -10.3 million 1.1 million
Dec. 31, 2025 629000 1.1 million
Sept. 30, 2025 -8.9 million 1.1 million

BDSX Net Income

No data available :(

BDSX Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 30.0 million 46.8 million 25.0 million
March 31, 2026 25.6 million 46.5 million 25.1 million
Dec. 31, 2025 19.0 million 47.4 million 25.4 million
Sept. 30, 2025 16.7 million 47.1 million 24.4 million

BDSX Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 10.3 million
March 31, 2026 9.7 million
Dec. 31, 2025 8.1 million
Sept. 30, 2025 7.5 million

BDSX Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 134000 3.1 million 24.3 million -
March 31, 2026 144000 3.3 million 24.3 million -
Dec. 31, 2025 149000 2.9 million 23.0 million -
Sept. 30, 2025 67000 3.0 million 21.7 million -

BDSX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 26.9 million 4.8 million
March 31, 2026 25.6 million 4.2 million
Dec. 31, 2025 28.8 million 4.9 million
Sept. 30, 2025 21.8 million 4.1 million

BDSX Revenue by Segment
Graph available only for paid members. Upgrade to see it.

BDSX

Price: $26.18

52 week price:
5.26
30.60

Earnings Per Share: -3.02 USD

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Country: United States

Volume: 306900

Market Capitalization: 256.5 million

Links: